IL6 and glioblastoma: Strong activation of STAT3 by epidermal growth factor (EGF), platelet-derived growth factor, transforming growth factor beta (TGFβ), and interleukin-6 (IL-6) serves as a crucial signal for the maintenance of GSCs and treatment resistance in GBM [12, 14].